Building a value-based approach to biologic drugs.

In the absence of comprehensive position papers from professional organizations on the complex issue of patient affordability of biologic therapies, the Jefferson School of Population Health reconvened a National Advisory Board to discuss the issue. The objectives of the board were to quantify the issues and to identify potential solutions - including a recommended approach for payers.